1339 GMT - - Bayer reported fourth-quarter results that were generally above Barclays's forecasts while 2025 group guidance for sales also came in slightly better at the midpoint. The midpoint of the Ebitda target was marginally above the bank's expectations, though free cash flow guide was set lower than Barclays's views, it says. The U.K. bank expects the focus of the company's earnings call to include the potential impact of tariffs, particularly on crop science, and free cash flow over the next couple of years. The bank had been forecasting free cash flow of 2.6 billion euros or 2025 versus company guidance of 1.5 billion to 2.5 billion euros. Barclays has an equal weight rating and 22 euro price target on the stock. Shares rise 3.1% at 24.25 euros. (dominic.chopping@wsj.com)
(END) Dow Jones Newswires
March 05, 2025 08:39 ET (13:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.